Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review
Zach Walsh, Özden Merve Mollaahmetoğlu, Joseph M. Rootman, et al.
BJPsych Open (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

The Neuropsychology of Anxiety
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024)
Closed Access | Times Cited: 73
A Decade of Dedication: Pioneering Perspectives on Neurological Diseases and Mental Illnesses
Masaru Tanaka, László Vécsei
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1083-1083
Open Access | Times Cited: 17
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Narrative Review: Low-Dose Ketamine for Pain Management
Alessandro Riccardi, Mario Guarino, Sossio Serra, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3256-3256
Open Access | Times Cited: 25
Opioid use disorder: current trends and potential treatments
Yu Kyung Lee, Mark S. Gold, Kenneth Blum, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 13
The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world
Stephanie Lake, Philippe Lucas
International Journal of Drug Policy (2024) Vol. 130, pp. 104507-104507
Closed Access | Times Cited: 8
Toward Synergies of Ketamine and Psychotherapy
David S. Mathai, Victoria Mora, Albert Garcia‐Romeu
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 31
Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism
Jennifer Mitchell, B. Anderson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 96-103
Open Access | Times Cited: 21
Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa
Johanna Louise Keeler, Janet Treasure, Hubertus Himmerich, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 19
Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings
Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, et al.
Frontiers in Human Neuroscience (2023) Vol. 17
Open Access | Times Cited: 19
At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data
David S. Mathai, Thomas D. Hull, Leonardo Vando, et al.
Journal of Affective Disorders (2024) Vol. 361, pp. 198-208
Open Access | Times Cited: 6
Occurrence of Z-drugs, benzodiazepines, and ketamine in wastewater in the United States and Mexico during the Covid-19 pandemic
Sangeet Adhikari, Rahul Kumar, Erin M. Driver, et al.
The Science of The Total Environment (2022) Vol. 857, pp. 159351-159351
Open Access | Times Cited: 27
Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions
Anya Ragnhildstveit, Matthew Slayton, Laura Jackson, et al.
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 382-382
Open Access | Times Cited: 22
Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses
Philip E. Wolfson, Julane Andries, Daniel Ahlers, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 14
Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach
Phil Wolfson, Gita Vaid
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Trends in Poisonings Involving Ketamine in the United States, 2019-2023
Joseph J. Palamar, Jennifer S. Jewell, Omar El‐Shahawy, et al.
Drug and Alcohol Dependence (2025) Vol. 268, pp. 112549-112549
Closed Access
The ketamine chameleon: history, pharmacology, and the contested value of experience
Danny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review
Theodore Piper, Francesca Small, Sam P. Brown, et al.
Addiction (2025)
Open Access
Strengthening Safeguards for Psychiatric Uses of Ketamine
Brian S. Barnett, Roger D. Weiss, Gerard Sanacora
JAMA Psychiatry (2025)
Closed Access
The Contribution of Psychotherapy in Potential Therapeutic Effects of Psychedelics for Treatment of Opioid Use Disorder
Anahita Bassir Nia, Yalda Farahmand, Gemma M. Griffith, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
Brain-derived neurotrophic factor (BDNF) changes in rodent models of schizophrenia induced by ketamine: a systematic review
Atefeh Motamedi-Manesh, Mahdieh Farzin Asanjan, Hamed Fallah, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Qualitative analysis of a patient's experience of ketamine-assisted psychotherapy for substance use disorder: Empirical synergies with twelve-step programs
Dan Petrovitch, Jacob Spinks, H.J. Yoo, et al.
Psychiatry Research Case Reports (2025), pp. 100259-100259
Open Access
Utilizing Psychedelics to Enhance Well-Being: A Systematic Review
Samuel Thomson, Nikos Thomacos
Journal of Psychoactive Drugs (2025), pp. 1-17
Open Access
Neuroplasticity and Psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models
Claudio Agnorelli, Meg J. Spriggs, Kate Godfrey, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 172, pp. 106132-106132
Open Access
Combined ketamine and psychotherapy provide no additional benefit beyond ketamine alone in treating depression or PTSD: Evidence from a help-seeking sample
Tyler M. Moore, Kathryn C. Walker, Elizabeth L. Tung, et al.
Journal of Affective Disorders (2025)
Closed Access
Page 1 - Next Page

Scroll to top